- Entry
- $1.74
- Now
- $1.50 -13.6%
- Target
- —
- Score
- —
MICROBOT MEDICAL INC. 10Q. I only bought into this the other day. Financial Performance Revenue: $105K — First-ever commercial revenue from the LIBERTY® Endovascular Robotic System. Gross Profit: $2K (Cost of revenues $103K). Net Loss: $(3.671)M vs. $(2.601)M in Q1 2025. Loss per Share: $(0.05) (basic/diluted). Balance Sheet & Liquidity Cash & Cash Equivalents: $3.657M (\~$3.66M). Marketable Securities: $68.843M (\~$68.84M). Total Liquidity (cash + marketable securities, excluding restricted): ≈ $72.5M. Strong runway — management believes sufficient for >12 months of …
— ORIGINAL POST ·
$MBOT 10Q - Q1
· r/pennystocks
· May 13, 2026